Anne B. Nielsen
Copenhagen, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Durability of RSV Prefusion F Vaccine Protection across Two RSV Seasons.
Journal: NEJM evidence
Published: August 29, 2026
RSV vaccine for preventing respiratory and cardiovascular hospitalizations in heart failure: a prespecified analysis of the extended DAN-RSV trial.
Journal: European journal of heart failure
Published: August 08, 2026
Effectiveness of Bivalent RSV Prefusion F Protein-based Vaccine in Individuals With and Without Atrial Fibrillation: A Prespecified Analysis of the DAN-RSV Trial.
Journal: Journal of the American College of Cardiology
Published: August 02, 2026
Effectiveness of High-Dose versus Standard-Dose Influenza Vaccine against Venous Thromboembolic Events: A Post Hoc Analysis of the DANFLU-2 Trial.
Journal: European journal of preventive cardiology
Published: July 31, 2026
Bivalent RSV Prefusion F Protein-Based Vaccine Effectiveness in Individuals With and Without Diabetes: A Prespecified Analysis of the DAN-RSV Trial.
Journal: Diabetes care
Published: March 05, 2026
Respiratory syncytial virus vaccination and risk of respiratory and cardiorespiratory hospitalization in adults with chronic kidney disease: a prespecified analysis of the DAN-RSV trial.
Journal: European journal of preventive cardiology
Published: January 29, 2026
High-Dose vs Standard-Dose Influenza Vaccine in Older Adults With Diabetes: A Secondary Analysis of the DANFLU-2 Randomized Clinical Trial.
Journal: JAMA internal medicine
Published: January 12, 2026
High-Dose Influenza Vaccine Effectiveness against Hospitalization in Older Adults.
Journal: The New England journal of medicine
Published: September 01, 2025
High-Dose vs Standard-Dose Influenza Vaccine and Cardiovascular Outcomes in Older Adults: A Prespecified Secondary Analysis of the DANFLU-2 Randomized Clinical Trial.
Journal: JAMA cardiology
Published: August 30, 2025
High-Dose Versus Standard-Dose Influenza Vaccine in Heart Failure: A Prespecified Analysis of the DANFLU-2 Trial.
Journal: Circulation. Heart failure
Published: August 30, 2025
Risk of Myocarditis or Pericarditis With High-Dose vs Standard-Dose Influenza Vaccine: A Prespecified Secondary Analysis of the Randomized DANFLU-2 Trial.
Journal: JAMA network open
Published: August 30, 2025
High-Dose vs Standard-Dose Influenza Vaccine in Older Adults With Atrial Fibrillation: A Prespecified Analysis of the DANFLU-2 Trial.
Journal: Journal of the American College of Cardiology
Published: July 31, 2025
Last Updated: 09/26/2026